BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2451525)

  • 1. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
    Filderman AE; Genovese LA; Lazo JS
    Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide.
    Phan SH; Fantone JC
    Lab Invest; 1984 May; 50(5):587-91. PubMed ID: 6201676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.
    Ekimoto H; Takada K; Takahashi K; Matsuda A; Takita T; Umezawa H
    J Antibiot (Tokyo); 1984 Jun; 37(6):659-63. PubMed ID: 6204963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamsters.
    Giri SN; Chen ZL; Younker WR; Schiedt MJ
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):132-41. PubMed ID: 6195772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bleomycin-induced pulmonary toxicity and related factors to that toxicity in experimental animals].
    Okayama H
    Tsurumi Shigaku; 1986 May; 12(2):245-57. PubMed ID: 2429414
    [No Abstract]   [Full Text] [Related]  

  • 7. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats.
    Iraz M; Erdogan H; Kotuk M; Yağmurca M; Kilic T; Ermis H; Fadillioğlu E; Yildirim Z
    Pharmacol Res; 2006 Mar; 53(3):310-6. PubMed ID: 16459098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
    Verma R; Brahmankar M; Kushwah L; Suresh B
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol alleviates bleomycin-induced lung injury in rats.
    Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
    Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol.
    Atzori L; Chua F; Dunsmore SE; Willis D; Barbarisi M; McAnulty RJ; Laurent GJ
    Thorax; 2004 Mar; 59(3):217-23. PubMed ID: 14985557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine strain differences in pulmonary bleomycin metabolism.
    Filderman AE; Lazo JS
    Biochem Pharmacol; 1991 Jun; 42(1):195-8. PubMed ID: 1712591
    [No Abstract]   [Full Text] [Related]  

  • 13. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents.
    Dong J; Yu X; Porter DW; Battelli LA; Kashon ML; Ma Q
    Arch Toxicol; 2016 Feb; 90(2):385-402. PubMed ID: 26345256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of pulmonary oxygen toxicity by bleomycin treatment.
    Matalon S; Harper WV; Goldinger JM; Nickerson PA; Olszowka J
    J Appl Physiol (1985); 1985 Jun; 58(6):1802-9. PubMed ID: 2409069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastase modifies bleomycin-induced pulmonary fibrosis in mice.
    Trajano LA; Trajano ET; Lanzetti M; Mendonça MS; Guilherme RF; Figueiredo RT; Benjamim CF; Valenca SS; Costa AM; Porto LC
    Acta Histochem; 2016 Apr; 118(3):203-12. PubMed ID: 26852294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung.
    Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E
    Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kehrer JP; Paraidathathu T
    Fundam Appl Toxicol; 1984 Oct; 4(5):760-7. PubMed ID: 6510607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of intratracheal bleomycin instillation on peroxidative processes in rat lung tissue].
    Ledwozyw A; Ruciński T; Synowiec R
    Pol Arch Weter; 1991; 31(3-4):115-23. PubMed ID: 1726838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
    Yildirim Z; Turkoz Y; Kotuk M; Armutcu F; Gurel A; Iraz M; Ozen S; Aydogdu I; Akyol O
    Nitric Oxide; 2004 Sep; 11(2):156-65. PubMed ID: 15491848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
    Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.